The Dilemma of Medical Marijuana Use by Rheumatology Patients

Authors

  • Mary-Ann Fitzcharles,

    Corresponding author
    1. McGill University Health Centre, Montreal, Quebec, Canada
    Search for more papers by this author
    • Dr. Fitzcharles has received consulting fees, speaking fees, and/or honoraria (less than $10,000 each) from Abbott, Amgen, Lilly, Pfizer, Purdue, and Valeant.

  • Daniel J. Clauw,

    1. University of Michigan Medical Center, Ann Arbor
    Search for more papers by this author
    • Dr. Clauw has received consulting fees, speaking fees, and/or honoraria (less than $10,000 each) and/or research grants from Cerephex, Forest, Johnson & Johnson, Lilly, Merck, Nuvo, Pfizer, Purdue, Theravance, and Tonix.

  • Peter A. Ste-Marie,

    1. McGill University Health Centre, Montreal, Quebec, Canada
    Search for more papers by this author
  • Yoram Shir

    1. McGill University Health Centre, Montreal, Quebec, Canada
    Search for more papers by this author

Ancillary